A lipoxin A 4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury

Journal of Molecular Neuroscience

Volumn 46, Issue 3, 2012, Pages 483-491

  Wu, Yan ^a   Wang, Yan Ping ^b   Guo, Peipei ^b   Ye, Xi Hong ^b   Wang, Jie ^b   Yuan, Shi Ying ^b   Yao, Shang Long ^b   Shang, You ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Blood brain barrier; Cerebral ischemia; Lipoxin; Matrix metalloproteinase

Indexed keywords

EVANS BLUE; GELATINASE B; LIPOXIN A; TRIPHENYLTETRAZOLIUM; LIPOXIN; LIPOXIN A4 METHYL ESTER; MMP9 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; STROKE; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; LIPOXINS; MALE; MATRIX METALLOPROTEINASE 9; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84859164095     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-011-9620-5     Document Type: Article

References (48)

1. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20(12):1681-1689
2. Asahi M, Wang X, Mori T et al (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21(19):7724-7732 (Pubitemid 32904971)
3. Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477(1-2):267-283 (Pubitemid 30119906)
4. Cezar-de-Mello PF, Vieira AM, Nascimento-Silva V, Villela CG, Barja- Fidalgo C, Fierro IM (2008) ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor. Br J Pharmacol 153(5):956-965 (Pubitemid 351328942)
5. Chen QH, Zhou WD, Pu DM, Huang QS, Li T, Chen QX (2010) 15-Epi-lipoxin A(4) inhibits the progression of endometriosis in a murine model. Fertil Steril 93(5):1440-1447
6. Chiang N, Fierro IM, Gronert K, Serhan CN (2000) Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 191(7):1197-1208
7. Chiang N, Arita M, Serhan CN (2005) Anti-inflammatory circultry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fat Acids 73(3-4):163-177 (Pubitemid 41253473)
8. Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR (1997) Increased gelatinase A(MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 238 (1-2):53-56
9. Crocker SJ, Pagenstecher A, Campbell IL (2004) The TIMPs tango with MMPs and more in the central nervous system. J Neurosci Res 75(1):1-11
10. Cunningham LA, Wetzel M, Rosenberg GA (2005) Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50(4):329-339 (Pubitemid 40780839)
11. Fujimura M, Gasche Y, Morita-Fujimura Y, Massengale J, Kawase M, Chan PH (1999) Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 842 (1):92-100 (Pubitemid 29447856)
12. Gasche Y, Fujimura M, Morita-Fujimura Y et al (1999) Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 19(9):1020-1028 (Pubitemid 30173725)
13. Gu Z, Kaul M, Yan B et al (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297(5584):1186-1190 (Pubitemid 36193354)
14. Heo JH, Lucero J, Abumiya T, Koziol JA, Copeland BR, del Zoppo GJ (1999) Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 19(6):624-633 (Pubitemid 30161214)
15. Hornebeck W, Lambert E, Petitfrère E, Bernard P (2005) Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochimie 87(3-4):377-383 (Pubitemid 40387617)
16. Horstmann S, Kalb P, Koziol J, Gardner H, Wagner S (2003) Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 34 (9):2165-2170 (Pubitemid 37099830)
17. Kauppinen TM, Swanson RA (2005) Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J Immunol 174 (4):2288-2296 (Pubitemid 40223977)
18. Kim CH, Moon SK (2005) Epigallocatechin-3-gallate causes the p21/ WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alphainduced vascular smooth muscle cells. Arch Biochem Biophys 435 (2):264-272 (Pubitemid 40222465)
19. Koh SH, Chang DI, Kim HT et al (2005) Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model. Toxicology 214(1-2): 131-139
20. Lee SR, Tsuji K, Lee SR, Lo EH (2004) Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 24(3):671-678 (Pubitemid 38166493)
21. Lee KJ, Jang YH, Lee H, Yoo HS, Lee SR (2008) PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition. Eur J Neurosci 27(2):334-342
22. Lo EH (2008) Experimental models, neurovascular mechanisms and translational issues in stroke research. Br J Pharmacol 153(Suppl 1):S396-S405
23. Lo EH, Wang X, Cuzner ML (2002) Extracellular proteolysis inbrain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 69(1):1-9 (Pubitemid 34734159)
24. Longa EZ, Weinstein PR, Carlson S, Cummins R. (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20(1):84-91 (Pubitemid 19040218)
25. Lu A, Clark JF, Broderick JP et al (2008) Reperfusion activates metalloproteinases that contribute to neurovascular injury. Exp Neurol 210(2):549-559
26. Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN (1997) Lipoxin A4stable analoges are potent mimetics that stimulate human monocytes and THP-1 cell via a G-protein linked lipoxin A4 receptor. J Biol Chem 272 (11):6972-6978 (Pubitemid 27166397)
27. Petasis NA, Keledjian R, Sun YP et al (2008) Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties. Bioorg Med Chem Lett 18 (4):1382-1387 (Pubitemid 351226538)
28. Pfefferkorn T, Rosenberg GA (2003) Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke 34(8):2025-2030 (Pubitemid 36944801)
29. Planas AM, Solé S, Justicia C, Farré ER (2000) Estimation of gelatinase content in rat brain: effect of focal ischemia. Biochem Biophys Res Commun 278(3):803-807
30. Planas AM, Solé S, Justicia C (2001) Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol Dis 8(5):834-846 (Pubitemid 33055599)
31. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29(5):1020-1030 (Pubitemid 28228167)
32. Rosenberg GA, Estrada EY, Dencoff JE (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (10):2189-2195 (Pubitemid 28443538)
33. Serhan CN, Oliw E (2001) Unorthodox routes toprostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest 107(12):1481-1489 (Pubitemid 32574630)
34. Serhan CN, Maddox JF, Petasis NA et al (1995) Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34(44):14609-14615 (Pubitemid 3000720)
35. Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8(5):349-361 (Pubitemid 351595216)
36. Sodin-Semrl S, Taddeo B, Tseng D, Varga J, Fiore S (2000) Lipoxin A4inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol 164(5):2660-2666 (Pubitemid 30115498)
37. Sodin-Semrl S, Spagnolo A, Mikus R, Barbaro B, Varga J, Fiore S (2004) Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor. Int J Immunopathol Pharmacol 17(2): 145-156
38. Svensson CI, Zattoni M, Serhan CN (2007) Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J Exp Med 204(2):245-252 (Pubitemid 46294540)
39. Wada K, Arita M, Nakajima A et al (2006) Leukotriene B4and lipoxin A4 are regulatory signals for neural stem cell proliferation and differentiation. FASEB J 20(11):1785-1792 (Pubitemid 44933792)
40. Wagner S, Nagel S, Kluge B et al (2003) Topographically graded postischemic presence of metalloproteinases is inhibited by hypothermia. Brain Res 984(1-2):63-75 (Pubitemid 36976795)
41. Wang X, Barone FC, White RF, Feuerstein GZ (1998) Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke. Stroke 29(2):516-520 (Pubitemid 28086700)
42. Wang X, Jung J, Asahi M et al (2000) Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 20(18): 7037-7042
43. Wu CY, Hsieh HL, Jou MJ, Yang CM (2004) Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J Neurochem 90(6):1477-1488
44. Wu SH, Liao PY, Dong L, Chen ZQ (2008) Signal pathway involved in inhibition by lipoxin A(4) of production of interleukins induced in endothelial cells by lipopolysaccharide. Inflamm Res 57(9):430-437
45. Wu Y, Ye XH, Guo PP et al (2010) Neuroprotective Effect of lipoxin A (4) methyl ester in a rat model of permanent focal cerebral ischemia. J Mol Neurosci 42(2):226-234
46. Ye XH, Wu Y, Guo PP et al (2010) Lipoxin A(4) analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Res 1323: 174-183
47. Yiqin Y, Meilin X, Jie X, Keping Z (2009) Aspirin inhibits MMP-2 and MMP-9 expression and activity through PPARalpha/gamma and TIMP-1-mediated mechanisms in cultured mouse celiac macrophages. Inflammation 32(4):233-241
48. Zhou XY, Li YS, Wu P et al (2009) Lipoxin A(4) inhibited hepatocyte growth factor-induced invasion of human hepatoma cells. Hepatol Res 39(9):921-930